BCL2 Expression and BCL2/MYC Dual Expression Correlates with Inferior Survival in Primary Central Nervous System Lymphoma

被引:0
|
作者
Uppal, G.
Wang, Z-X
Bajaj, R.
Curtis, M.
Solomides, C. C.
Glass, J.
Banks, P.
Peiper, S. C.
Gong, J. Z.
机构
[1] Thomas Jefferson Univ Hosp, Philadelphia, PA 19107 USA
[2] Ventana Med Syst Inc, Tucson, AZ USA
关键词
D O I
暂无
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
1571
引用
收藏
页码:383A / 383A
页数:1
相关论文
共 50 条
  • [31] Inter- and intratumoral heterogeneity of BCL2 correlates with IgH expression and prognosis in follicular lymphoma
    A Barreca
    C Martinengo
    L Annaratone
    L Righi
    A Chiappella
    M Ladetto
    A Demurtas
    L Chiusa
    A Stacchini
    N Crosetto
    A van Oudenaarden
    R Chiarle
    Blood Cancer Journal, 2014, 4 : e249 - e249
  • [32] The Impact of Concurrent MYC BCL2 Protein Expression on the Risk of Secondary Central Nervous System Relapse in Diffuse Large B- Cell Lymphoma (DLBCL)
    Savage, Kerry J.
    Sehn, Laurie H.
    Villa, Diego
    Kansara, Roopesh R.
    Mottok, Anja
    Ennishi, Daisuke
    Ben-Neriah, Susana
    Kridel, Robert
    Steidl, Christian
    Tan, King L.
    Johnson, Nathalie
    Slack, Graham W.
    Connors, Joseph M.
    Farinha, Pedro
    Scott, David W.
    Gascoyne, Randy D.
    BLOOD, 2014, 124 (21)
  • [33] Inter- and intratumoral heterogeneity of BCL2 correlates with IgH expression and prognosis in follicular lymphoma
    Barreca, A.
    Martinengo, C.
    Annaratone, L.
    Righi, L.
    Chiappella, A.
    Ladetto, M.
    Demurtas, A.
    Chiusa, L.
    Stacchini, A.
    Crosetto, N.
    van Oudenaarden, A.
    Chiarle, R.
    BLOOD CANCER JOURNAL, 2014, 4 : e249 - e249
  • [34] BCL2 expression is associated with a poor prognosis independent of cellular origin in primary central nervous system diffuse large B-cell lymphoma
    Makino, Keishi
    Shinojima, Naoki
    Kuroda, Jun-Ichiro
    Yano, Shigetoshi
    Mikami, Yoshiki
    Mukasa, Akitake
    BRAIN PATHOLOGY, 2019, 29 : 125 - 125
  • [35] BCL2 expression is associated with a poor prognosis independent of cellular origin in primary central nervous system diffuse large B-cell lymphoma
    Keishi Makino
    Hideo Nakamura
    Naoki Shinojima
    Jun-ichiro Kuroda
    Shigetoshi Yano
    Yoshiki Mikami
    Akitake Mukasa
    Journal of Neuro-Oncology, 2018, 140 : 115 - 121
  • [36] Double-hit or dual expression of MYC and BCL2 in primary cutaneous large B-cell lymphomas
    Menguy, Sarah
    Frison, Eric
    Prochazkova-Carlotti, Martina
    Dalle, Stephane
    Dereure, Olivier
    Boulinguez, Serge
    Dalac, Sophie
    Machet, Laurent
    Ram-Wolff, Caroline
    Verneuil, Laurence
    Gros, Audrey
    Vergier, Beatrice
    Beylot-Barry, Marie
    Merlio, Jean-Philippe
    Pham-Ledard, Anne
    MODERN PATHOLOGY, 2018, 31 (08) : 1332 - 1342
  • [37] Double-hit and dual expression of MYC and BCL2 in primary cutaneous large B-cell lymphomas
    Menguy, Sarah
    Frison, Eric
    Prochazkova-Carlotti, Martina
    Dalle, Stephane
    Dereure, Olivier
    Boulinguez, Serge
    Dalac, Sophie
    Machet, Laurent
    Ram-Wolff, Caroline
    Verneuil, Laurence
    Gros, Audrey
    Vergier, Beatrice
    Beylot-Barry, Marie
    Merlio, Jean-Philippe
    Pham-Ledard, Anne
    EUROPEAN JOURNAL OF CANCER, 2019, 119 : S20 - S20
  • [38] BCL2 expression is associated with a poor prognosis independent of cellular origin in primary central nervous system diffuse large B-cell lymphoma
    Makino, Keishi
    Nakamura, Hideo
    Shinojima, Naoki
    Kuroda, Jun-ichiro
    Yano, Shigetoshi
    Mikami, Yoshiki
    Mukasa, Akitake
    JOURNAL OF NEURO-ONCOLOGY, 2018, 140 (01) : 115 - 121
  • [39] Bcl2 (B cell lymphoma)
    不详
    BULLETIN DU CANCER, 1998, 85 (09) : 738 - 738
  • [40] A BCL2 promoter polymorphism rs2279115 is not associated with BCL2 protein expression or patient survival in breast cancer patients
    Searle, Claire J.
    Brock, Ian W.
    Cross, Simon S.
    Balasubramanian, Sabapathy P.
    Reed, Malcolm W. R.
    Cox, Angela
    SPRINGERPLUS, 2012, 1